Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Xenon gas vs standard anesthetic: which keeps blood pressure steadier during carotid surgery?

NCT ID NCT00937807

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This completed Phase 4 trial tested whether xenon gas (LENOXe) can keep blood pressure as stable as sevoflurane during carotid artery surgery in 84 elderly patients. The study measured blood pressure changes every minute during surgery. Researchers also looked at safety, recovery quality, and pain levels. The goal was to see if xenon is a good alternative for this specific procedure.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
xenon gas
What this could lead to
If xenon proves non-inferior to sevoflurane, it could offer an alternative anesthetic with similar blood pressure stability for elderly patients undergoing carotid surgery.
What could go wrong
This is a small, completed Phase 4 trial with only 84 participants. Results may not apply to broader populations or other surgeries. Xenon is expensive and not widely available.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 4

Runs after approval, following long-term safety and how well the treatment works in everyday use.

Participants

84 people

The number who actually took part.

Start date

Jul 2009

Finished

Apr 2010

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

55 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients \> 55 years, status ASA II * Carotid endarterectomy elected surgery * Signed informed consent Exclusion Criteria: Related to the patients: * Histories of hypersensibility in both products used in the study * uncontrolled arterial High Blood Pressure in the preoperative anaesthesia screening * Severe cardiac failure (FEVG \< 30 %) * Major lung or airways disease and\\or required per-operating FiO2\> 35 % * Elevated intracranial pressure * Pregnancy, breast feeding * Major protected, under supervision, under guardianship * Every patient entering within the framework of the contraindications indicated to §4.3 of the summary of the characteristics of tested products (LENOXe ™ (xenon 100 % v/v), sevoflurane) Related to the surgery: * Controlateral carotid stenosis superior to 70 % and\\or preoperative indication in the implementation per-operating of a carotid shunt * Surgery realized within the framework of an emergency * Combined Surgery

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Carotid artery stenosis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hospital Pitié-Salpêtrière

    Paris, 75013, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.